Barr Modifies Request to Sell ‘Morning-After’ Pill

Barr Pharmaceuticals Inc. filed a modified request with U.S. regulators to sell its “morning-after” emergency contraceptive pill without a prescription.

Neither the Food and Drug Administration nor Barr would say what changes the company made to its application for the pill, called Plan B.

The FDA this month said it was prepared to quickly approve Plan B if Barr increased the age it proposed for over-the-counter sales from 16 to 18 and met other conditions.